These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension.
    Author: Skalska AB, Pietrzycka A, Stepniewski M.
    Journal: Clin Biochem; 2009 Mar; 42(4-5):358-64. PubMed ID: 19046960.
    Abstract:
    UNLABELLED: Experimental studies confirmed that reactive oxygen species increase endothelin-1 (ET-1) synthesis, and modulate ET-1 signaling pathway resulting in vasoconstriction and vascular remodeling. The aim of this study was to evaluate the relationship between plasma ET-1 concentration and antioxidant status in patients with essential hypertension and type 2 diabetes mellitus. METHODS: 78 hypertensive patients, 53.8% diabetic, mean age 72.1+/-7.07 were examined. The plasma concentration of glucose, creatinine, uric acid, bilirubin, cholesterol, insulin, HbA1c and ET-1 were measured. Antioxidant status was assessed by Ferric Reducing Ability of Plasma (FRAP), vitamin C concentration and erythrocyte superoxide dismutase (SOD) activity. RESULTS: With diabetes ET-1 concentration was higher (1.35+/-0.51 vs 1.12+/-0.46 pg/mL, p=0.04). The negative correlations between ET-1 concentration and FRAP (r=-0.50, p<0.0001), vitamin C (r=-0.296, p=0.01) and SOD (r=-0.44, p=0.001) were found. Concentration of ET-1 correlated positively with SBP (r=0.33, p=0.005) but not with DBP. The relationship between DBP and ET-1 only in subjects with DBP>110 mm Hg and FRAP<0.40 mmol/L was found. In multiple regression analysis plasma ET-1 levels were associated independently with FRAP (beta=-0.583, p=0.003) and plasma vitamin C (beta=-0.407, p=0.04). CONCLUSIONS: In hypertensive and diabetic patients higher plasma endothelin-1 level was independently associated with lower plasma antioxidant status measured by FRAP and decreased vitamin C concentration, which may be a result of increased oxidative stress in these diseases.
    [Abstract] [Full Text] [Related] [New Search]